| Website | pieris-ag.com |
| Category | BioTech |
| Phone | +49 (0) 8161 14 11 400 |
| Employees | |
| Founded | 2001 |
| Description | Biopharmaceutical |
| TOTAL | $45.9M |
| VENTURE FUNDING TOTAL | $45.9M |
| Series B, 11/06 AAC Capital Partners BayTech Venture Capital Gilde Investment Management BioM AG Global Life Science Ventures | $6.39M |
| Series B, 3/08 Novo Nordisk | $39.5M |
Pieris was established in 2001 with the vision of commercially exploiting technologies developed originally by Prof. Dr. Arne Skerra, Head of the Department of Biological Chemistry at the Technical University of Munich (TUM), Germany. While the scientific excellence of Prof. Dr. Skerra and his fellow Pieris co-founders has long been recognized by the academic community, the product commercialization potential of their discoveries was acknowledged through Pieris’ attainment in 2000 of first prize in the Munich Business Plan Contest.
